Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.465
-0.085 (-5.48%)
Jan 2, 2026, 1:55 PM EST - Market open
Equillium Market Cap
Equillium has a market cap or net worth of $89.21 million as of January 2, 2026. Its market cap has increased by 257.19% in one year.
Market Cap
89.21M
Enterprise Value
62.01M
1-Year Change
257.19%
Ranking
Category
Stock Price
$1.47
Market Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $89.21M, a decrease of -61.96%. That is a compound annual growth rate of -12.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |